Fournier's gangrene due to Candida glabrata

Medical Mycology

Volumn 46, Issue 2, 2008, Pages 171-173

  Loulergue, Pierre ^a   Mahe, Veronique ^a   Bougnoux, Marie Elisabeth ^a   Poiree, Sylvain ^b   Hot, Arnaud ^a   Lortholary, Olivier ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Antifungals; Candida; Fournier's gangrene; Necrotizing fasciitis

Indexed keywords

AMPHOTERICIN B; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CANDIDA GLABRATA; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIABETES CONTROL; DIABETES MELLITUS; DOSE RESPONSE; FOURNIER GANGRENE; FUNGUS GROWTH; GENITAL SYSTEM EXAMINATION; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; NONHUMAN; PATHOGENESIS; TREATMENT DURATION; URINALYSIS;

CANDIDA GLABRATA; CANDIDIASIS; FOURNIER GANGRENE; HUMANS; MALE; MIDDLE AGED;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 40649118065     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780701636567     Document Type: Article

References (13)

1. Laor, E., Palmer, LS, Tolia, BM, Reid, RE and Winter, HI. (1995) Outcome prediction in patients with Fournier's gangrene. J Urol, 1, pp. 89-92.
2. Yeniyol, CO, Suelozgen, T., Arslan, M. and Ayder, AR. (2004) Fournier's gangrene: Experience with 25 patients and use of Fournier's gangrene severity index score. Urology, 2, pp. 218-222.
3. Norton, KS, Johnson, LW and Perry, T. (2002) Management of Fournier's gangrene: An eleven year retrospective analysis of early recognition, diagnosis, and treatment. Am Surg, 8, pp. 709-713.
4. Johnin, K., Nakatoh, M. and Kadowaki, T. (2000) Fournier's gangrene caused by Candida species as the primary organism. Urology, 1, p. 153.
5. Tayib, AM, Mosli, HA, Abdulwahab, MH and Atwa, MA. (2003) Fournier's gangrene in diabetic and renal failure patients. Saudi Med J, 10, pp. 1105-1108.
6. Nucci, M. and Marr, KA. (2005) Emerging fungal diseases. Clin Infect Dis, 4, pp. 521-526.
7. Wai, PH, Ewing, CA and Johnson, LB (2001) Candida fasciitis following renal transplantation. Transplantation, 3, pp. 477-479.
8. Gallup, DG, Freedman, MA, Meguiar, RV, Freedman, SN and Nolan, TE. (2002) Necrotizing fasciitis in gynecologic and obstetric patients: A surgical emergency. Am J Obstet Gynecol, 2, pp. 305-310.
9. Pfaller, MA and Diekema, DJ. (2004) Twelve years of fluconazole in clinical practice: Global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect, 1, pp. 11-23.
10. Fidel Jr, PL, Vazquez, JA and Sobel, JD. (1999) Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol Rev, 1, pp. 80-96.
11. Pfaller, MA, Boyken, L. and Messer, SA (2004) Evaluation of the etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida species. J Clin Microbiol, 11, pp. 4977-4979.
12. Lortholary, O., Raoux, D., Hoinard, D. and Dromer, F. In vitro susceptibility to posaconazole of 1327 yeasts isolates recovered from bloodstream infections in France (2003-2006) using the EUCAST method. Abstract M-1590-46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) San Francisco
13. Aridogan, IA, Ilkit, M., Izol, V. and Ates, A. (2005) Malassezia and Candida colonisation on glans penis of circumcised men. Mycoses, 5, pp. 352-356.